Today: 29 June 2026
Brambles share price rises on buyback update as March dividend date nears
24 February 2026
1 min read

Brambles share price rises on buyback update as March dividend date nears

Sydney, Feb 24, 2026, 18:05 AEDT — Market shut its doors for the day.

  • Brambles Limited picked up 1.3%, ending Tuesday at A$24.84.
  • New ASX filings revealed plans for more buybacks and the cancellation of 77,358 shares.
  • Focus shifts now to how quickly buybacks ramp up ahead of the March 11 ex-dividend date.

Brambles Limited finished up 1.3% at A$24.84 on Tuesday, with shares moving between A$24.31 and A$24.91. The pallet pooling company reported increased action on its on-market buyback.

This is significant—buybacks are among the rare levers visible daily to investors. Put simply, with an on-market buyback, a company steps in to buy its own stock right on the exchange, a process that gradually reduces the number of shares out there.

It comes as investors brace for the coming weeks of capital returns. As Brambles approaches its dividend cutoff, traders increasingly focus on the share price, weighing the yield and the backing from the buyback.

Brambles reported in its daily ASX filing that on Feb. 23, it repurchased 77,358 shares for A$1.89 million, paying between A$24.14 and A$24.54 per share. Prior to that, the company had already bought back 12,287,724 shares. There’s still headroom: Brambles can purchase up to another 124,334,223 shares under its current cap. The buyback program is set to continue through June 30.

The filing also lists 77,358 ordinary shares set for cancellation on Feb. 25, tied to an on-market buyback. The price: A$1.887 million, according to the document.

Brambles lodged an application to quote 307 ordinary shares issued through its performance share plan, priced at A$23.9856 apiece. It’s a minor issuance tied to an employee scheme.

During the half-year call, CEO Graham Chipchase pointed to a big draw for customers: “easier to do business with us.” CFO Joaquin Gil, responding to Rimor Equity Research’s Scott Ryall on capex and pallet balances, added, “cashflow performance is sustainable.” Brambles Corporate Site

Brambles, in its half-year update, tightened its FY26 sales revenue growth guidance to a 3%-4% range at constant currency, holding the line on its 8%-11% forecast for underlying profit and bumping up free cash flow estimates now to between US$950 million and US$1.1 billion. The company set its interim dividend at 23 U.S. cents per share, or 32.74 Australian cents, with shares going ex-dividend on March 11 and the payment scheduled for April 9.

The stock last traded at A$24.84, putting it roughly 8% under its 52-week peak of A$26.93, but still comfortably higher than its low point of A$19.06 for the year, Barchart data show.

Still, there’s only so much juice left in capital returns for now. Brambles has already pointed to demand headwinds and volume uncertainty. If softness crops up again, pallet turns could slip, sending repair and transport costs higher. And should the stock price stay above the buyback range, every dollar spent nets the company fewer shares.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • SpaceX (SPCX) shares fade after IPO pop; attention turns to Nasdaq-100 inclusion
    June 29, 2026, 1:43 PM EDT. SpaceX (NASDAQ: SPCX) jumped as high as $225 from its $135 IPO, but slipped back to near $155. The company is still losing cash even with $4.7 billion Q1 2026 revenue. Some see index funds as forced buyers if SPCX gets added to the Nasdaq-100, which could bring new demand and help counter worries about valuation and the risk from lock-up expiry. Analysts point to SpaceX's strong position in launches and Starlink's global network, but note ongoing cash burn and no dividend. Some investors now look at the current price as a possible opportunity with index inclusion ahead as the next big event.
Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Previous Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus
Next Story

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus

Go toTop